301–350 of 20,598 genesranked by Most Researched

#	Gene	Name	Chr	Tags	PubMed Papers
301	MYH9	myosin heavy chain 9	22	Highly ConstrainedReceptor	712
302	RAF1	Raf-1 proto-oncogene, serine/threonine kinase	3	KinaseOncogene	709
303	XRCC5	X-ray repair cross complementing 5	2	DNA RepairHighly Constrained	708
304	CETP	cholesteryl ester transfer protein	16	TransporterClinical Trials	706
305	FASLG	Fas ligand	1	Clinical TrialsOMIM Disease Gene	706
306	S100A9	S100 calcium binding protein A9	1	Highly StudiedTrending	704
307	GNAS	GNAS complex locus	20	Highly ConstrainedOncogene	699
308	ITGAV	integrin subunit alpha V	2	ReceptorFDA Approved Target	698
309	MPO	myeloperoxidase	17	Clinical TrialsOMIM Disease Gene	696
310	TP73	tumor protein p73	1	Transcription FactorTumor Suppressor	693
311	CHEK2	checkpoint kinase 2	22	DNA RepairKinase	690
312	POU5F1	POU class 5 homeobox 1	6	Highly ConstrainedTranscription Factor	688
313	KCNH2	potassium voltage-gated channel subfamily H member 2	7	Ion ChannelTransporter	686
314	CUL1	cullin 1	7	Highly ConstrainedHighly Studied	685
315	NCL	nucleolin	2	Highly ConstrainedHighly Studied	685
316	PML	PML nuclear body scaffold	15	OncogeneTumor Suppressor	685
317	NRAS	NRAS proto-oncogene, GTPase	1	OncogeneClinical Trials	684
318	XIAP	X-linked inhibitor of apoptosis	X	Highly ConstrainedOMIM Disease Gene	684
319	FOXM1	forkhead box M1	12	DNA RepairTranscription Factor	682
320	TOP2A	DNA topoisomerase II alpha	17	FDA Approved TargetHighly Studied	681
321	F8	coagulation factor VIII	X	Highly ConstrainedFDA Approved Target	679
322	HBA1	hemoglobin subunit alpha 1	16	FDA Approved TargetHighly Studied	678
323	PRKAA1	protein kinase AMP-activated catalytic subunit alpha 1	5	KinaseFDA Approved Target	677
324	STUB1	STIP1 homology and U-box containing protein 1	16	DNA RepairOMIM Disease Gene	676
325	SNAI1	snail family transcriptional repressor 1	20	Highly StudiedTrending	672
326	NAMPT	nicotinamide phosphoribosyltransferase	7	Highly ConstrainedClinical Trials	671
327	CYP2E1	cytochrome P450 family 2 subfamily E member 1	10	Highly StudiedExperimental GO Evidence	670
328	EZR	ezrin	6	Highly StudiedExperimental GO Evidence	668
329	FYN	FYN proto-oncogene, Src family tyrosine kinase	6	Highly ConstrainedKinase	667
330	TTR	transthyretin	18	TransporterFDA Approved Target	665
331	DDB1	damage specific DNA binding protein 1	11	DNA RepairHighly Constrained	659
332	IRS1	insulin receptor substrate 1	2	Clinical TrialsOMIM Disease Gene	659
333	OGG1	8-oxoguanine DNA glycosylase	3	DNA RepairOMIM Disease Gene	656
334	FGF23	fibroblast growth factor 23	12	FDA Approved TargetOMIM Disease Gene	654
335	PPARA	peroxisome proliferator activated receptor alpha	22	ReceptorTranscription Factor	654
336	CLU	clusterin	8	Clinical TrialsHighly Studied	653
337	ZEB1	zinc finger E-box binding homeobox 1	10	Highly ConstrainedOMIM Disease Gene	653
338	MAOA	monoamine oxidase A	X	Highly ConstrainedFDA Approved Target	652
339	NQO1	NAD(P)H quinone dehydrogenase 1	16	Clinical TrialsHighly Studied	652
340	POLR2A	RNA polymerase II subunit A	17	OMIM Disease GeneHighly Studied	652
341	RETN	resistin	19	Highly StudiedExperimental GO Evidence	652
342	DICER1	dicer 1, ribonuclease III	14	Highly ConstrainedOMIM Disease Gene	650
343	F3	coagulation factor III, tissue factor	1	FDA Approved TargetHighly Studied	649
344	GDF15	growth differentiation factor 15	19	OMIM Disease GeneHighly Studied	649
345	IKBKB	inhibitor of nuclear factor kappa B kinase subunit beta	8	KinaseClinical Trials	649
346	USP7	ubiquitin specific peptidase 7	16	DNA RepairHighly Constrained	648
347	PPIA	peptidylprolyl isomerase A	7	ApoptosisFDA Approved Target	647
348	CST3	cystatin C	20	OMIM Disease GeneHighly Studied	646
349	PLAUR	plasminogen activator, urokinase receptor	19	ReceptorHighly Studied	645
350	KEAP1	kelch like ECH associated protein 1	19	FDA Approved TargetHighly Studied	643